Jeanette Weidner
CIK: 0002158946
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)1 (100.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
GANX
Gain Therapeutics, Inc.
Officer
Discretionary Trading P&L
Holdings
About Weidner Jeanette
Weidner Jeanette (SEC CIK 0002158946) files insider reports with the SEC as Officer of Gain Therapeutics, Inc. (GANX).
Signal8 holds 2 ownership filings by Weidner Jeanette (1 Form 3, 1 Form 4), filed on Oct 30, 2026. Those filings report 1 transaction, the latest on Oct 29, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Weidner Jeanette's filings is in BETHESDA, MD.
Recent filings by Weidner Jeanette
- Oct 29, 2026: Grant or award of GANX derivative securities (Form 4, code A).
Other insiders filing for Gain Therapeutics, Inc. (GANX)
- GOLDSTEIN DOV A MD, Director
- Nicaise Claude, Director
- Islam Khalid, Director
- Melincoff Gwen A, Director
- Riley Jeffrey Scott, Director
- HASLER HANS PETER, Director